Analysts Set DocGo Inc. (NASDAQ:DCGO) PT at $3.21

DocGo Inc. (NASDAQ:DCGO) has earned a consensus rating of “Hold” from the seven analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $3.2125.

Several brokerages recently commented on DCGO. Weiss Ratings reissued a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. Zacks Research upgraded shares of DocGo from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Finally, Canaccord Genuity Group reduced their price target on DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a research report on Wednesday, November 12th.

DocGo Stock Performance

Shares of DCGO stock opened at $0.75 on Friday. The business’s 50 day moving average price is $0.86 and its 200-day moving average price is $1.15. The firm has a market cap of $72.91 million, a P/E ratio of -1.43 and a beta of 0.95. DocGo has a fifty-two week low of $0.66 and a fifty-two week high of $5.68.

Institutional Trading of DocGo

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. P.A.W. Capital Corp increased its holdings in DocGo by 60.0% in the 2nd quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company’s stock valued at $5,024,000 after acquiring an additional 1,200,000 shares during the last quarter. S Squared Technology LLC boosted its stake in DocGo by 52.2% during the second quarter. S Squared Technology LLC now owns 2,878,286 shares of the company’s stock valued at $4,519,000 after buying an additional 987,310 shares during the last quarter. Millennium Management LLC grew its holdings in DocGo by 878.6% during the 3rd quarter. Millennium Management LLC now owns 766,210 shares of the company’s stock valued at $1,042,000 after buying an additional 687,911 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in DocGo by 205.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 805,427 shares of the company’s stock worth $707,000 after acquiring an additional 541,670 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of DocGo by 219.1% during the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock worth $1,258,000 after acquiring an additional 327,269 shares in the last quarter. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.